Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Tullis Health Investors
AddedFeb 15, 2024
UpdatedJun 28, 2026
Tullis Health Investors

Tullis Health Investors

Operating

Tullis Health Investors: A private equity group specializing in healthcare sector investments.

Location
Stamford, CT, US
Founded
1986
Firm
Compare
Portfolio
Employees
Website

Tullis Health Investors is a private equity group specializing in healthcare sector investments. The firm focuses on high-margin, high-growth opportunities in medical devices, healthcare services and technology, specialty pharmaceuticals, and biotechnology. Their investment strategy targets novel products and services with the potential for long-term value creation.

Notable portfolio companies include Exagen, a diagnostics company that has raised over $137 million, and SupplyPro, a healthcare supply chain management solution. Tullis Health Investors emphasizes building real companies with scalable and commercial potential, aiming to make a significant impact on global health through their investments in innovative healthcare solutions.

Tullis Health Investors - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments13
Current Portfolio Count4
Total Portfolio Exits0

Top Investment Stages

Series Unknown7 (53.8%)
Debt Financing2 (15.4%)
Series A2 (15.4%)
Series B1 (7.7%)
Series C1 (7.7%)

Stage Mix

Series Unknown 54%Debt Financing 15%Series A 15%Series B 8%Series C 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Exagen logo

Exagen

Impulse Monitoring logo

Impulse Monitoring

SupplyPro logo

SupplyPro

Centromine logo

Centromine

Tullis Health Investors - Similar Investment Firms

Trellis Health Ventures logo

Trellis Health Ventures

WindRose Health Investors logo

WindRose Health Investors

windrose.com

Epsilon Health Investors logo

Epsilon Health Investors

epsilonhi.com

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Tenex Medical Investors logo

Tenex Medical Investors

HealthEdge Investment Partners logo

HealthEdge Investment Partners

Enhanced Healthcare Partners logo

Enhanced Healthcare Partners

HealthQuest Capital logo

HealthQuest Capital

HealthInvest Equity Partners logo

HealthInvest Equity Partners

VentureHealth logo

VentureHealth

venturehealth.com

InnovaHealth Partners logo

InnovaHealth Partners

Thurston Group logo

Thurston Group

thurstongroup.com

Concord Health Partners logo

Concord Health Partners

concordhp.com

Jumpstart Health Investors logo

Jumpstart Health Investors

jumpstarthealth.co

Healthlink Capital logo

Healthlink Capital

Tullis Health Investors - Classification

Also Known As
  • Tullis Health Investors, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end